Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

Health & Medicine

Tips for treating—even preventing—osteoarthritis

When it comes to daily aches and pains, it's not uncommon for knees to be a main source. And while there can be many different long-term causes of such issues, osteoarthritis is often a reason why.

Tips for treating—even preventing—osteoarthritis

Osteoarthritis, a common cause of knee pain and stiffness, affects more than 30 million adults in the U.S. The condition occurs when the cartilage between knee bones wears down, leading to reduced joint mobility and increased risk of other chronic diseases. Factors that increase the risk of osteoarthritis include excess weight, weak leg muscles, aging, prior injury, being female, and having a family history of the condition.

Despite its prevalence, osteoarthritis can be managed and even prevented. A healthy lifestyle, including a balanced diet rich in fruits, vegetables, and whole grains, can reduce inflammation and alleviate pain. Regular physical activity, including running, strengthens leg muscles and supports joint health. Maintaining a healthy weight is crucial, as losing even 10 pounds can significantly reduce stress on the knees.

Strengthening the thigh muscles, using knee braces, and taking anti-inflammatory medications or injections can also help manage symptoms. In severe cases, knee replacement surgery may be necessary. While osteoarthritis cannot be entirely prevented, adopting these healthy behaviors can significantly lower the risk and improve overall quality of life.

Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at medicalxpress.com →

More in Health & Medicine

SK Biopharmaceuticals Settles XCOPRI U.S. Patent Dispute

SK Biopharmaceuticals announced on August 19 that it has reached an amicable settlement with the Indian generic company MSN Laboratories in a United States patent litigation regarding its innovative…

  • SK Biopharmaceuticals settles patent dispute with MSN Laboratories.
  • Agreement allows MSN Laboratories to market generic cenobamate (XCOPRI) under patent.
  • Settlement resolves pending litigation at Delaware District Court.

More from Wednesday 19 August →